Title Statements
- Full title :Evidence-based cardiology / Christopher P. Cannon, Benjamin A. Steinberg.
Summary
Thoroughly updated for its Third Edition, this pocket-sized handbook provides easy access to clinical trial data that are crucial in therapeutic decision-making. The book enables clinicians to quickly review the studies that support or refute an intervention and choose the most appropriate, cost-effective treatment. Each chapter summarizes the pathophysiology of a disease and guideline-recommended diagnostic tests and treatments, and presents synopses of the major clinical trials for all therapies. New sections in this Third Edition cover peripheral artery disease and drug-eluting stents. This.
Read More ↓Edition Statements
- Publication Date:2011
- Edition:3rd ed
Publication Statements
- Publisher(s):Wolters Kluwer/Lippincott Williams & Wilkins Health
- Place of Publication:Philadelphia
- Language:eng
- Publication Date:2011
Notes
Revised edition of: Evidence-based cardiology / Peter J. Sharis, Christopher P. Cannon. c2003.
The Physical Object
- Description:1 online resource (xv, 480 pages) : : illustrations
Edition Identifiers
- ISBN:9781469876542, 146987654X, 1451124643, 9781451124644
- oclc:ocn690106783
- LC Classification:RC669.15
- Dewey Decimal:616.1/2
Table of Contents
EVIDENCE-BASED CARDIOLOGY; CONTENTS; PREFACE; CONTRIBUTORS; 1. Preventive Cardiology: Risk Factors for Coronary Artery Disease and Primary and Secondary Prevention Trials; CHOLESTEROL, LIPIDS, AND DIET; Epidemiology; National Cholesterol Education Program Guidelines; DIET AND VITAMINS; Special Diets; DRUGS; Bile Resins (e.g., Cholestyramine, Colestipol); Fibric Acid Derivatives (e.g., Gemfibrozil, Fenofibrate); Cholesterol Absorption Inhibitors; 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors (Statins); PRIMARY PREVENTION TRIALS; SECONDARY PREVENTION TRIALS.
COMBINED PRIMARY AND SECONDARY PREVENTION TRIALSEARLY STATIN INITIATION TRIALS; Raising HDL Cholesterol; NIACIN; SMOKING; DIABETES; Metabolic Syndrome; HYPERTENSION; Epidemiology; Etiology; Diagnosis, Joint National Committee 7 Classification; Treatment; NONPHARMACOLOGIC; PHARMACOLOGIC; Target Blood Pressure; OBESITY; SEDENTARY LIFESTYLE AND EXERCISE; NONMODIFIABLE RISK FACTORS; Family History; Age; Gender; ALCOHOL; HORMONAL STATUS AND HORMONAL THERAPY; C-REACTIVE PROTEIN; OTHER POTENTIAL RISK FACTORS; Homocysteine; Lipoprotein-associated Phospholipase A2; Infection; Genetic Markers.
ANTIPLATELET DRUGS FOR PRIMARY…
Subjects
Writers
More from this Series
No reviews yet. Be the first to rate this work.
Files & Downloads
-
Evidence-Based Cardiology -- (.pdf)
PDF · 2.8 MB · updated
Rate & Review